mesh condition

Psychomotor Agitation
Intelligence

Psychomotor Agitation intelligence: 18 indexed trials, 4 recruiting studies, 17 sponsors across 11 countries.

⚗
18Indexed trials
↗
4Recruiting
▦
17Sponsors
◎
11Countries

Leading sponsors

Axsome Therapeutics, Inc.20 recruiting
Assistance Publique - Hôpitaux de Paris10 recruiting
Eastern Virginia Medical School11 recruiting
Eli Lilly and Company10 recruiting
George Washington University10 recruiting
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.11 recruiting
Icahn School of Medicine at Mount Sinai10 recruiting
JHSPH Center for Clinical Trials11 recruiting
Johns Hopkins University10 recruiting
MJHS Institute for Innovation in Palliative Care10 recruiting
National Institute of Mental Health (NIMH)10 recruiting
National Institute of Nursing Research (NINR)10 recruiting

Geographic activity

United States15trials
Canada3trials
Puerto Rico2trials
Germany1trials
Norway1trials
Russia1trials
Serbia1trials
Spain1trials
Ukraine1trials
France1trials
Croatia1trials

Leading interventions

AXS-05 (dextromethorphan-bupropion)2trials
Risperidone2trials
Brexpiprazole, OPC-347121trials
Citalopram1trials
Dronabinol (Marinol®)1trials
Escitalopram1trials
Gabapentin1trials
Ferrous Sulfate1trials
Heteroquestionnaires1trials
High Active intervention1trials
Inactive intervention1trials
Caregiver reminiscence with coaching1trials

Methodology note

This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.